NCT02629289 A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants Status COMPLETED Phase PHASE1
NCT02625207 THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC Status COMPLETED Phase PHASE1
NCT02624973 PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02623049 Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation Status UNKNOWN Phase N/A
NCT02622581 Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients Status RECRUITING Phase N/A
NCT02616185 A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR) Status TERMINATED Phase PHASE1
NCT02614482 Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children. Status COMPLETED Phase PHASE3
NCT02613650 A Trial of mFOLFIRI With MEK162 in Patients With Advanced RAS (HRAS, NRAS, or KRAS) Positive Metastatic Colorectal Cancers Status COMPLETED Phase PHASE1
NCT02612194 LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer Status TERMINATED Phase PHASE2
NCT02609828 Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy Status COMPLETED Phase PHASE3
NCT02609139 Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02607254 Efficacy and Safety of Pregabalin in Treatment of Neuropathic Pain in Patients With Idiopathic Small Fiber Neuropathy Status COMPLETED Phase PHASE2
NCT02605642 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade Status COMPLETED Phase N/A
NCT02605486 Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02603432 A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) Status COMPLETED Phase PHASE3
NCT02603419 Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS) Status TERMINATED Phase PHASE1
NCT02602704 Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients Status COMPLETED Phase PHASE4
NCT02600923 Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate Status COMPLETED Phase PHASE3
NCT02597322 Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN) Status COMPLETED Phase PHASE2